Suchergebnisse - (Person:"Wagner, Kathryn R")

PubPharm (197)

41

Safety, tolerability, and pharmacokinetics of casimersen in patients with Duchenne muscular dystrophy amenable to exon 45 skipping : A randomized, double-blind, placebo-controlled, dose-titration trial

enthalten in: Muscle & nerve | 2021

von Wagner, K. | Kuntz, N. | Koenig, E. | +4

42

A phase Ib/IIa, open-label, multiple ascending-dose trial of domagrozumab in fukutin-related protein limb-girdle muscular dystrophy

enthalten in: Muscle & nerve | 2021

von Leung, D. | Bocchieri, A. | Ahlawat, S. | +10

43

Human muscle stem cells are refractory to aging

enthalten in: Aging cell | 2021

von Novak, J. | Mázala, D. | Nearing, M. | +12

44

CaMKII oxidation is a critical performance/disease trade-off acquired at the dawn of vertebrate evolution

enthalten in: Nature communications | 2021

von Wang, Q. | Hernández-Ochoa, E. | Viswanathan, M. | +21

45

Mss51 deletion increases endurance and ameliorates histopathology in the mdx mouse model of Duchenne muscular dystrophy

enthalten in: FASEB journal : official publication of the Federation of American Societies for Experimental Biology | 2021

von Rovira Gonzalez, Y. | Moyer, A. | LeTexier, N. | +10

46

Corrigendum to "Randomized phase 2 trial and open-label extension of domagrozumab in Duchenne muscular dystrophy" [Neuromuscular Disorders, Vol. 30 (6) 2020, 492-502

enthalten in: Neuromuscular disorders : NMD | 2021

von Wagner, K. | Abdel-Hamid, H. | Mah, J. | +21

ErratumFor: Neuromuscul Disord. 2020 Jun;30(6):492-502. - PMID 32522498

47

Open-Label Evaluation of Eteplirsen in Patients with Duchenne Muscular Dystrophy Amenable to Exon 51 Skipping : PROMOVI Trial

enthalten in: Journal of neuromuscular diseases | 2021

von McDonald, C. | Shieh, P. | Abdel-Hamid, H. | +12

48

A Randomized, Double-Blind, Placebo-Controlled, Global Phase 3 Study of Edasalonexent in Pediatric Patients with Duchenne Muscular Dystrophy : Results of the PolarisDMD Trial

enthalten in: Journal of neuromuscular diseases | 2021

von Finkel, R. | McDonald, C. | Lee Sweeney, H. | +24

49

Human muscle stem cells are refractory to aging

enthalten in: Aging Cell | 2021

von Novak, J. | Mázala, D. | Nearing, M. | +12

50

Mss51 deletion increases endurance and ameliorates histopathology in the mdx mouse model of Duchenne muscular dystrophy

enthalten in: The FASEB Journal | 2021

von Rovira Gonzalez, Y. | Moyer, A. | LeTexier, N. | +10